Three-dimensional human tissue models that incorporate diabetic foot ulcer-derived fibroblasts mimic in vivo features of chronic wounds

Tissue Engineering - Part C: Methods

Volumn 21, Issue 5, 2015, Pages 499-508

  Maione, Anna G ^a   Brudno, Yevgeny ^b,c   Stojadinovic, Olivera ^d   Park, Lara K ^e   Smith, Avi ^e   Tellechea, Ana ^f,g   Leal, Ermelindo C ^f   Kearney, Cathal J ^b,c,h   Veves, Aristidis ^f   Tomic Canic, Marjana ^d   Mooney, David J ^b,c   Garlick, Jonathan A ^e  

^a TUFTS UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

^c HARVARD UNIVERSITY   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e TUFTS UNIVERSITY SCHOOL OF DENTAL MEDICINE   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF COIMBRA   (Portugal)

^h ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; DISEASES; FIBROBLASTS; MAMMALS; TISSUE REGENERATION;

CLINICAL APPLICATION; DIABETES MELLITUS; DIABETIC FOOT ULCER; EFFECTIVE THERAPY; EXTRACELLULAR MATRIX DEPOSITION; MATCHED CONTROLS; RE-EPITHELIALIZATION; THREE-DIMENSIONAL (3D) MODEL;

THREE DIMENSIONAL COMPUTER GRAPHICS;

GAMMA INTERFERON; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NFF PROTEIN; PROTEIN; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; CYTOKINE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRIGHT FIELD MICROSCOPY; CELL COMPOSITION; CELL CULTURE; CELL MOTILITY; CELL PROLIFERATION; CHRONIC WOUND; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETIC FOOT; ENDOTHELIUM CELL; EPITHELIZATION; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HEALING IMPAIRMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SKIN FIBROBLAST; WOUND CLOSURE; WOUND HEALING; ANIMAL; C57BL MOUSE; CELL CULTURE TECHNIQUE; CYTOLOGY; FIBROBLAST; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; TISSUE ENGINEERING;

MUS;

ANIMALS; CELL CULTURE TECHNIQUES; CYTOKINES; DIABETIC FOOT; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; IN VITRO TECHNIQUES; KERATINOCYTES; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; TISSUE ENGINEERING; WOUND HEALING;

EID: 84928943198     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2014.0414     Document Type: Article

References (37)

1. Boulton, A.J.M., Vileikyte, L., Ragnarson-Tennvall, G., and Apelqvist, J. The global burden of diabetic foot disease. Lancet 366, 1719, 2005.
2. Carlson, M.W., Alt-Holland, A., Egles, C., and Garlick, J.A. Three-dimensional tissue models of normal and diseased skin. Curr Protoc Cell Biol Editor Board Juan Bonifacino Al Chapter 19, Unit 19.9 2008.
3. Breslin, S., and O'Driscoll, L. Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today 18, 240, 2013.
4. Singer, A.J., and Clark, R.A. Cutaneous wound healing. N Engl J Med 341, 738, 1999.
5. Brem, H., et al. Primary cultured fibroblasts derived from patients with chronic wounds: a methodology to produce human cell lines and test putative growth factor therapy such as GMCSF. J Transl Med 6, 75, 2008.
6. Green, J.A., and Yamada, K.M. Three-dimensional microenvironments modulate fibroblast signaling responses. Adv Drug Deliv Rev 59, 1293, 2007.
7. Pouyani, T., et al. De novo synthesis of human dermis in vitro in the absence of a three-dimensional scaffold. In Vitro Cell Dev Biol Anim 45, 430, 2009.
8. Shamis, Y., et al. iPSC-derived fibroblasts demonstrate augmented production and assembly of extracellular matrix proteins. In Vitro Cell Dev Biol Anim 48, 112, 2012.
9. Proia, D.A., and Kuperwasser, C. Reconstruction of human mammary tissues in a mouse model. Nat Protoc 1, 206, 2006.
10. Brudno, Y., Ennett-Shepard, A.B., Chen, R.R., Aizenberg, M., and Mooney, D.J. Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors. Biomaterials 34, 9201, 2013.
11. Segal, N., et al. The basement membrane microenvironment directs the normalization and survival of bioengi-neered human skin equivalents. Matrix Biol J Int Soc Matrix Biol 27, 163, 2008.
12. Egles, C., Garlick, J.A., and Shamis, Y. Three-dimensional human tissue models of wounded skin. Methods Mol Biol Clifton NJ 585, 345, 2010.
13. Kong, H.J., Kaigler, D., Kim, K., and Mooney, D.J. Controlling rigidity and degradation of alginate hydrogels via molecular weight distribution. Biomacromolecules 5, 1720, 2004.
14. Lerman, O.Z., Galiano, R.D., Armour, M., Levine, J.P., and Gurtner, G.C. Cellular dysfunction in the diabetic fibro-blast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 162, 303, 2003.
15. Blakytny, R., and Jude, E. The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med J Br Diabet Assoc 23, 594, 2006.
16. Koch, A., et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258, 1798, 1992.
17. Gallagher, K.A., et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 117, 1249, 2007.
18. Dinh, T., et al. Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes 61, 2937, 2012.
19. Stojadinovic, O., et al. Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol 167, 59, 2005.
20. Usui, M.L., Mansbridge, J.N., Carter, W.G., Fujita, M., and Olerud, J.E. Keratinocyte migration, proliferation, and differentiation in chronic ulcers from patients with diabetes and normal wounds. J Histochem Cytochem Off J His-tochem Soc 56, 687, 2008.
21. Werner, S., Krieg, T., and Smola, H. Keratinocyte-fibro-blast interactions in wound healing. J Invest Dermatol 127, 998, 2007.
22. Loots, M.A., et al. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 111, 850, 1998.
23. Kota, S.K., et al. Aberrant angiogenesis: the gateway to diabetic complications. Indian J Endocrinol Metab 16, 918, 2012.
24. Nakatsu, M.N., et al. Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1. Microvasc Res 66, 102, 2003.
25. Shamis, Y., et al. Fibroblasts derived from human plurip-otent stem cells activate angiogenic responses in vitro and in vivo. PLoS One 8, e83755, 2013.
26. Stojadinovic, O., Zabielinski, M., and Tomic-Canic, M. Healing competence of the keratinocytes and the chronic wound edge. Adv Wound Care 1, 171, 2010.
27. Stojadinovic, O., et al. Deregulation of keratinocyte differentiation and activation: a hallmark of venous ulcers. J Cell Mol Med 12, 2675, 2008.
28. Garlick, J.A. Engineering skin to study human disease-tissue models for cancer biology and wound repair. Adv Biochem Eng Biotechnol 103, 207, 2007.
29. Safferling, K., et al. Wound healing revised: a novel re-epithelialization mechanism revealed by in vitro and in silico models. J Cell Biol 203, 691, 2013.
30. Lobmann, R., et al. Expression of matrix-metalloprotei-nases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 45, 1011, 2002.
31. Engerman, R.L., and Kern, T.S. Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 36, 808, 1987.
32. Pirola, L., Balcerczyk, A., Okabe, J., and El-Osta, A. Epi-genetic phenomena linked to diabetic complications. Nat Rev Endocrinol 6, 665, 2010.
33. Pirola, L., et al. Genome-wide analysis distinguishes hy-perglycemia regulated epigenetic signatures of primary vascular cells. Genome Res 21, 1601, 2011.
34. Benazzoug, Y., Borchiellini, C., Labat-Robert, J., Robert, L., and Kern, P. Effect of high-glucose concentrations on the expression of collagens and fibronectin by fibroblasts in culture. Exp Gerontol 33, 445, 1998.
35. Yevdokimova, N.Y. High glucose-induced alterations of extracellular matrix of human skin fibroblasts are not dependent on TSP-1-TGFbeta1 pathway. J Diabetes Complications 17, 355, 2003.
36. Bouhadir, K., et al. Degradation of partially oxidized al-ginate and its potential application for tissue engineering. Biotechnol Prog 17, 945, 2001.
37. Rowley, J.A., Madlambayan, G., and Mooney, D.J. Algi-nate hydrogels as synthetic extracellular matrix materials. Biomaterials 20, 45, 1999.